Karen Smirnakis

Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease

Stephen Salloway, Spyros Chalkias, Frederik Barkhof et al. · JAMA Neurology · 2021 · 584 citations · Full text

Medicine, Neurology, Pharmacology +16

Effects of AMG 145 on Low-Density Lipoprotein Cholesterol Levels

Clapton Dias, Adam J. Shaywitz, Scott M. Wasserman et al. · Journal of the American College of Cardiology · 2012 · 234 citations

Life Sciences, Biochemistry, Nutritional Sciences +12

Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing

Lana Zhovtis Ryerson, John Foley, Ih Chang et al. · Neurology · 2019 · 194 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +16

Inflammation and Glucose Intolerance

Myles Wolf, Jenny Sauk, Anand Shah et al. · Diabetes Care · 2004 · 174 citations · Full text

Medicine, Endocrinology, Obstetrics +13

Postpartum Diabetes Screening in Women With a History of Gestational Diabetes

Karen Smirnakis, Lisa Chasan‐Taber, Myles Wolf et al. · Obstetrics and Gynecology · 2005 · 146 citations

Public Health, Maternal Health, Obstetrics +17